Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

TS 01

Next Previous
Drug Profile

TS 01

Alternative Names: mproUK; mutant prourokinase; TS01

Latest Information Update: 01 Oct 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Beth Israel Deaconess Medical Center; Harvard Medical School
  • Developer Thrombolytic Science International
  • Class Complement C1 inactivator proteins; Neuroprotectants; Recombinant proteins; Thrombolytics; Vascular disorder therapies
  • Mechanism of Action Fibrinolytic agents; Urokinase-type plasminogen activator stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Ischaemic stroke

Most Recent Events

  • 24 Sep 2024 US FDA approves IND application for TS 01 in clinical trial (In volunteers)
  • 24 Sep 2024 Thrombolytic Science International plans a phase II trial for Myocardial infarction in United Kingdom
  • 24 Sep 2024 Thrombolytic Science International plans a clinical trial (In volunteers) in USA

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top